Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 7
2014 16
2015 6
2016 2
2017 8
2018 10
2019 16
2020 9
2021 14
2022 18
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort.
Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I, Sangiovanni V, Rossomando A, Pacilio R, Calabria G, Pisapia R, Carriero C, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N; CoviCam group. Grimaldi P, et al. Infection. 2024 Apr;52(2):439-446. doi: 10.1007/s15010-023-02095-8. Epub 2023 Sep 13. Infection. 2024. PMID: 37704910 Free PMC article.
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.
Viceconte G, Buonomo AR, D'Agostino A, Foggia M, Di Fusco A, Pinchera B, Scotto R, Iacovazzo C, Fanasca L, Messina G, Cacciatore F, Salvatore P, Gentile I, On Behalf Of The Federico Ii Covid Team. Viceconte G, et al. Among authors: buonomo ar. J Fungi (Basel). 2023 Aug 11;9(8):838. doi: 10.3390/jof9080838. J Fungi (Basel). 2023. PMID: 37623609 Free PMC article.
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study.
Calò F, Onorato L, De Luca I, Macera M, Monari C, Durante-Mangoni E, Massa A, Gentile I, Di Caprio G, Pagliano P, Numis FG, Iuliano P, Buonomo AR, Leone S, Maggi P, Coppola N. Calò F, et al. Among authors: buonomo ar. J Infect Public Health. 2023 Sep;16(9):1485-1491. doi: 10.1016/j.jiph.2023.06.009. Epub 2023 Jun 14. J Infect Public Health. 2023. PMID: 37349243 Free article.
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE - a multi-centre experience in Italy.
Gentile I, Buonomo AR, Corcione S, Paradiso L, Giacobbe DR, Bavaro DF, Tiseo G, Sordella F, Bartoletti M, Palmiero G, Vozza A, Vena A, Canta F, Moriello NS, Congera P, Karruli A, Tascini C, Viale P, Bono VD, Falcone M, Carbonara S, Mikulska MK, Bassetti M, Durante-Mangoni E, De Rosa FG, Maraolo AE. Gentile I, et al. Among authors: buonomo ar. Int J Antimicrob Agents. 2023 Jul;62(1):106817. doi: 10.1016/j.ijantimicag.2023.106817. Epub 2023 Apr 13. Int J Antimicrob Agents. 2023. PMID: 37061102 Free article.
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic.
Pietroluongo E, De Placido P, Picozzi F, Morra R, Tortora M, Del Deo V, Montella L, Palmieri G, Buonomo AR, De Placido S, Gentile I, Giuliano M. Pietroluongo E, et al. Among authors: buonomo ar. Mediastinum. 2022 Jun 14;7:8. doi: 10.21037/med-21-47. eCollection 2023. Mediastinum. 2022. PMID: 36926294 Free PMC article. No abstract available.
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study.
Scotto R, Buonomo AR, Iuliano A, Foggia M, Sardanelli A, Villari R, Pinchera B, Gentile I, Federico Ii Covid-Team. Scotto R, et al. Among authors: buonomo ar. Vaccines (Basel). 2023 Jan 17;11(2):200. doi: 10.3390/vaccines11020200. Vaccines (Basel). 2023. PMID: 36851078 Free PMC article.
110 results